Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of novel HCV inhibitor L-0909

Sep. 9, 2019

China's NMPA approves Focus V for third-line treatment of SCLC

Sep. 6, 2019

European Commission approves Lonsurf for metastatic gastric cancer

Sep. 6, 2019

Universite de Liege discovers new antibacterials

Sep. 6, 2019

Adlai Nortye discloses adenosine A2A and/or A2B receptor antagonists

Sep. 6, 2019

Sinovent presents new E-NPP 2 inhibitors

Sep. 6, 2019

European Commission approves Tecentriq for extensive-stage SCLC and non-squamous NSCLC

Sep. 6, 2019

Merck & Co. describes HIV integrase inhibitors

Sep. 6, 2019

Medshine Discovery divulges FGFR inhibitors

Sep. 6, 2019

A novel preclinical model of cocaine and alcohol coabuse

Sep. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...